Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis

Ha-young Lee1, Eun-ha Shin, Yoe-sik Bae

  • 1Medical Research Center for Cancer Molecular Therapy, College of Medicine, Dong-A University, Busan 602-714, Korea.

Acta Pharmacologica Sinica
|September 30, 2006
PubMed
Summary

Sphingosylphosphorylcholine (SPC) drives dendritic cell (DC) migration by activating specific signaling pathways. This suggests a unique SPC receptor, distinct from S1P receptors, regulates DC trafficking.